Since we could not detect any differences in the analysis of NOSTRIN hsa-miR-214-5p between preeclampsia vs. control (NOSTRIN: preeclampsia vs. control: 1.8 × 10−6 vs. 1.0 × 10−6; p = 0.07) (Figure 5a), we analyzed target genes for hsa-miR-1270 (ANGPTL7 and TFRC). The gene discussed is TFRC; the disease is preeclampsia.